Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer
STAT1α and STAT1β blocked activation of TGF-β1 signaling pathway in EOC cells.
»
05/11/18
Association of body mass index and outcomes following lobectomy for non-small-cell lung cancer
Underweight patients experienced significantly more operative mortality, respiratory complications.
»
05/11/18
Expression of the cervical carcinoma expressed PCNA regulatory (CCEPR) long noncoding RNA is driven by the human papillomavirus E6 protein and modulates cell proliferation independent of PCNA.
HPV16 E6 oncogene expression causes increased CCEPR expression.
»
12/19/17
The microRNA-371~373 cluster represses colon cancer initiation and metastatic colonization by inhibiting the TGFBR2/ID1 signaling axis.
miR-371~373/TGFBR2/ID1 signaling axis as novel regulatory mechanism of TIC self-renewal.
»
05/07/18
Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance.
Poor PFS associated with ATM mutation.
»
12/06/17
Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy.
3-month PSA level found to be predictive of OS in high-risk group.
»
09/17/17
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer.
Tumor infiltrating lymphocytes (TILs) associated with improved prognosis in TNBC.
»
04/26/18
Immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy alone versus immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy in combination with anti-RANKL denosumuab in malignant melanoma: a retrospective analysis at a tertiary care center.
Combination therapy (denosumab + immune checkpoint inhibitors) may have beneficial effect on survival.
»
05/12/18
Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer.
Synaptotagmin XIII expressed at significantly higher levels in patients with peritoneal recurrence.
»
12/30/17
PTPN12/PTP-PEST Regulates Phosphorylation-Dependent Ubiquitination and Stability of Focal Adhesion Substrates in Invasive Glioblastoma Cells.
Perturbing PTP-PEST-mediated phosphorylation of Cas and Vcp led to alterations in GBM cell invasive growth.
»
05/07/18
< Prev
Next >